Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Evolutionary changes may have influenced metabolism and increased risk of diabetes

Researchers at the University of California, San Diego School of Medicine and Rady Children's Hospital-San Diego say an evolutionary gene mutation that occurred in human millions of years ago and our subsequent inability to produce a specific kind of sugar molecule appears to make people more vulnerable to developing type 2 diabetes, especially if they're overweight.

25 Feb 2011

Research sheds new light on problem of insulin resistance in type 2 diabetes

A research team, led by La Jolla Institute scientist Joel Linden, Ph.D., has shed new light on the problem of insulin resistance, and identified the key participants in a molecular pathway that holds therapeutic promise for reducing the severity of type 2 diabetes.

25 Feb 2011

Experts at ICAO warn about risk of cardiometabolic consequences in overweight individuals

Experts meeting at the 2nd International Congress on Abdominal Obesity today issued a warning that millions of individuals around the globe are at risk from the cardiometabolic consequences of being overweight. Worryingly, the experts suggest that these people are not being identified by their doctors.

25 Feb 2011

Omega-3 fish oils: Natural health solution for the heart

Did you know that over the average life span, a heart beats 2 to 3 billion times? As one of the hardest working muscles pumping oxygen and essential nutrients throughout your body an average of 100,000 times a day, the heart needs a lot of help to stay working fit.

25 Feb 2011

Research: Loss of CMAH's function may make humans more prone to obesity and diabetes

As if the recent prediction that half of all Americans will have diabetes or pre-diabetes by the year 2020 isn't alarming enough, a new genetic discovery published online in the FASEB Journal provides a disturbing explanation as to why: we took an evolutionary "wrong turn."

25 Feb 2011

Study: More effective therapies needed for diabetes patients with ESRD

Despite significant advances in kidney care over the past 20 years, efforts to improve therapy for type 1 diabetes patients with kidney dysfunction remain unsuccessful, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology. The results suggest that more effective therapies are needed for these patients.

24 Feb 2011

Study: Individuals with fatty liver more likely to develop type 2 diabetes

A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that individuals with fatty liver were five times more likely to develop type 2 diabetes than those without fatty liver. This higher risk seemed to occur regardless of the patient's fasting insulin levels, which were used as a marker of insulin resistance.

24 Feb 2011

Simple home urine test can measure insulin in patients with diabetes

A simple home urine test has been developed which can measure if patients with Type 1 and Type 2 diabetes are producing their own insulin. The urine test, from Professor Andrew Hattersley's Exeter-based team at the Peninsula Medical School, replaces multiple blood tests in hospital and can be sent by post as it is stable for up to three days at room temperature.

24 Feb 2011

Excess weight contributes to higher risk of death in Asians

A study of more than 1 million Asians found that those who were a normal weight were far less likely to die from any cause than individuals whose body-mass index (BMI) was too high or low. A similar association was seen between BMI and the risk of death from cancer, cardiovascular disease or other causes.

24 Feb 2011

Researchers study mobile health technology options to help patients manage diabetes

The McKesson Foundation today announced the six recipients of $1.3 million in research grants as part of its Mobilizing for Healthsm initiative to improve the health of underserved populations with chronic diseases through the use of mobile-phone technology.

24 Feb 2011

FDA approves ONGLYZA to treat type 2 diabetes patients with renal impairment

Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration has approved the inclusion of data from two clinical studies in an update to the ONGLYZA U.S. Prescribing Information for adult type 2 diabetes patients.

24 Feb 2011

Positive results from Harbor BioSciences' Triolex initial preclinical study for treatment of PD

Harbor BioSciences, Inc., which is investigating the use the company's proprietary compound Triolex as a treatment for Parkinson's disease with funding from The Michael J. Fox Foundation, announced positive results in initial preclinical studies.

23 Feb 2011

Higher intake of vitamin D may reduce breast cancer risk

Researchers at the University of California, San Diego School of Medicine and Creighton University School of Medicine in Omaha have reported that markedly higher intake of vitamin D is needed to reach blood levels that can prevent or markedly cut the incidence of breast cancer and several other major diseases than had been originally thought. The findings are published February 21 in the journal Anticancer Research.

23 Feb 2011

TransPharma completes ViaDor-GLP1 agonist Phase 1b trial for treatment of type II diabetes

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.

22 Feb 2011

Red and processed meats – How much to include in diet?

A latest Government-commissioned report advises people to eat less red meat and processed meat saying that it lowers the risk of developing cancer. The report will advise consumers eat no more than 2.5 oz (70g) of red or processed meat a day – the equivalent of three rashers of bacon. Also the weekly recommended limit is likely to be 1.1 lb (500g), the same as eating a large pack of minced beef, two 8oz steaks or four 4oz pork chops. The farming and retail industries are, as predictable, not happy with the directives.

22 Feb 2011

Study: Gastric bypass surgery may lead to better health outcomes in patients with diabetes

Gastric bypass surgery appears to lead to better long-term results including greater weight loss, resolution of diabetes and improved quality of life compared with sleeve gastrectomy and "lap-band" surgery, according to two reports in the February issue of Archives of Surgery, one of the JAMA/Archives journals.

22 Feb 2011

CDC maps least and most active Americans

A new government commissioned study has found that Colorado has one of the most active populations in the country and Kentucky has one of the least active. This study is the third in a series of county-focused reports by the federal Centers for Disease Control and Prevention (CDC). The first two looked at diabetes and obesity rates, says Ann Albright, director of the CDC’s Division of Diabetes Translation.

20 Feb 2011

American researcher awarded European Research Council Advanced Grant

One of the goals of the European Research Council, ERC, is to bring the world's leading researchers to work in Europe. American Juleen Zierath is one of those who have received funds from the ERC. She found the best environment for her research at Karolinska Institutet in Sweden.

19 Feb 2011

FDA recognizes safety and efficacy of True Results LAP-BAND device

The True Results team of gastric band surgeons and medical weight loss experts is pleased the U.S. Food and Drug Administration has recognized the long-standing safety and effectiveness record of the LAP-BAND System.

19 Feb 2011

Fine-Gray competing-risks analysis may predict ESRD mortality in patients with type 1 diabetes

Patients with both type 1 diabetes and CKD have an increased risk of adverse outcomes. Despite aggressive treatment, many patients with type 1 diabetes and overt nephropathy develop End-Stage Renal Disease and/or succumb to a premature death. The competing risks of death and ESRD may confound the estimates of risk for each outcome.

18 Feb 2011

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Evolutionary changes may have influenced metabolism and increased risk of diabetes

Research sheds new light on problem of insulin resistance in type 2 diabetes

Experts at ICAO warn about risk of cardiometabolic consequences in overweight individuals

Omega-3 fish oils: Natural health solution for the heart

Research: Loss of CMAH's function may make humans more prone to obesity and diabetes

Study: More effective therapies needed for diabetes patients with ESRD

Study: Individuals with fatty liver more likely to develop type 2 diabetes

Simple home urine test can measure insulin in patients with diabetes

Excess weight contributes to higher risk of death in Asians

Researchers study mobile health technology options to help patients manage diabetes

FDA approves ONGLYZA to treat type 2 diabetes patients with renal impairment

Positive results from Harbor BioSciences' Triolex initial preclinical study for treatment of PD

Higher intake of vitamin D may reduce breast cancer risk

TransPharma completes ViaDor-GLP1 agonist Phase 1b trial for treatment of type II diabetes

Red and processed meats – How much to include in diet?

Study: Gastric bypass surgery may lead to better health outcomes in patients with diabetes

CDC maps least and most active Americans

American researcher awarded European Research Council Advanced Grant

FDA recognizes safety and efficacy of True Results LAP-BAND device

Fine-Gray competing-risks analysis may predict ESRD mortality in patients with type 1 diabetes

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in